Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J van Henten

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[A patient with generalized actinomycosis]A H Gerards, J van den Bosch, M J van Henten, et al.
Investigational New Drugs|September 6, 2007
Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patientsSandra Beijer, Eric A R Gielisse, Pierre S Hupperets, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2016
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung TrialSolange Peters, Rolf A Stahel, Urania Dafni, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[A patient with generalized actinomycosis]A H Gerards, J van den Bosch, M J van Henten, et al.
Investigational New Drugs|September 6, 2007
Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patientsSandra Beijer, Eric A R Gielisse, Pierre S Hupperets, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2016
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung TrialSolange Peters, Rolf A Stahel, Urania Dafni, et al.
Pageof 1